The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades.
Tag: Endocrinology
Endocrine Society supports federal legislation protecting IVF access
The Endocrine Society is calling for members of Congress to support federal legislation protecting access to in vitro fertilization (IVF).
Latest Science Shows Endocrine Disrupting Chemicals in Plastics, Pesticides, and Other Sources Pose Health Threats Globally
A report from the world’s leading scientific and medical experts on hormone-related health conditions raises new concerns about the profound threats to human health from endocrine disrupting chemicals (EDCs) that are ubiquitous in our surroundings and everyday lives.
ENDO 2024 opens media registration
Members of the media can now register to cover hormone health and science advances being presented at ENDO 2024, the Endocrine Society’s annual meeting. The meeting will take place June 1-4, in Boston, Mass.
Leading experts share latest science on global health threats from endocrine disrupting chemicals
As delegates from around the world meet at the sixth session of the U.N. Environmental Assembly (UNEA-6), a new report raises concerns about the profound threats to human health from endocrine-disrupting chemicals (EDCs) that are ubiquitous in our surroundings and everyday lives.
What’s on Your Plate?
The Food Pyramid that many of us learned about in school is now ancient history. That old guideline on food groups and servings has been replaced by MyPlate.
Women face greater risk of obesity in low- and middle-income countries
Women in low- and middle-income countries, especially in the Sub-Saharan Africa region, may be 10 times more likely to have obesity or heart health issues than their male counterparts, according to a large meta-analysis published in The Journal of Clinical Endocrinology and Metabolism.
Virtual Science Writers Conference will examine obesity treatments and heart health
Endocrine Society experts will discuss how these medications and bariatric surgery can treat obesity and improve cardiometabolic health, during the Society’s Virtual Science Writers Conference on November 9.
Study reveals how estrogen exerts its anti-diabetic effects
The quintessential female sex hormone estrogen stimulates cells that line blood vessels to deliver insulin to muscles, lowering blood sugar and protecting against Type 2 diabetes, UT Southwestern Medical Center researchers report. The findings, published in Nature Communications, could eventually lead to new therapies for Type 2 diabetes, a disease that affects hundreds of millions of people around the globe and continues to grow more prevalent.
Felix Beuschlein announced as winner of 2024 Transatlantic Alliance Award in Endocrinology
The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce that they have awarded the 2024 Transatlantic Alliance Award to Professor Felix Beuschlein, MD.
Children with prediabetes and obesity may be more likely to progress to diabetes
A new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for prevention, such as anti-obesity or anti-diabetes medication and lifestyle changes.
Primary care intervention reduces hypoglycemia risk from type 2 diabetes overtreatment in older adults
A newly published quality improvement study shows how a simple intervention by health care providers reduced the number of older adult patients with type 2 diabetes at risk for hypoglycemia (low blood sugar) by almost 50% and led to de-escalation of diabetes medications that cause hypoglycemia in 20% of patients.
Pediatric endocrinologists concerned for safety amid divisive political climate
Pediatric endocrinologists are concerned for their safety and their ability to provide evidenced-based care to transgender and gender-diverse adolescents amid political divides over gender-affirming care, according to a new paper published in the Journal of the Endocrine Society.
Adrenocortical carcinoma: No mitotane for low risk of recurrence
In 2017, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of Mitotane in the prevention of recurrence in adrenocortical carcinoma.
Endocrine Society honors endocrinology field’s leaders with 2024 Laureate Awards
The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2024 Laureate Awards, the top honors in the field.
UC San Diego Health Nationally Recognized for Stroke and Diabetes Care
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
UC San Diego Health Ranks No. 1 in San Diego, Makes National Honor Roll
U.S. News & World Report ranks 10 medical and surgical specialties at UC San Diego Health among the nation’s best.
Endocrine Society’s Journal of the Endocrine Society earns first Impact Factor
The Endocrine Society’s Journal of the Endocrine Society (JES) received its first Impact Factor score in 2022, while the Society’s other journals maintained high rankings on the prestigious measure of scholarly publishing.
Light or moderate alcohol consumption does not guard against diabetes, obesity
People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.
Social isolation linked to reduced bone quality in males, mouse study finds
Social isolation may negatively impact bone health, suggests a study conducted in mice being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Single hospital study finds transgender teenagers rarely choose to discontinue hormone therapy
A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Transgender people seen in the ER much more likely than cisgender people to be admitted to hospital
Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are much more likely to be admitted to the hospital once they visit the ER, according to a study being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Gaps remain in identifying, treating obesity despite new treatment options
By being undiagnosed or untreated, a significant fraction of people with obesity or overweight are not getting the recommended care, despite an increase in new treatment options, according to research being presented on June 17 at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Employees with obesity may have higher loss of work productivity than those with normal weight
People with obesity may have lower work productivity due to increased risk of illness, contributing to increased costs for employers, according to industry-supported research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.
Study finds “robotic pill” can safely deliver injectable osteoporosis drug
A proven and effective medication for osteoporosis, which is currently only available as an injection, can be administered orally using a novel “robotic pill,” according to a study presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Closed-loop insulin delivery systems may improve blood sugar control in children with type 1 diabetes
Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Prevalence of metabolic associated fatty liver disease is increasing
The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Endocrine Society Scientific Statement distinguishes normal aging from endocrine disease
A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention.
Endocrine-disrupting chemicals may raise risk of cognitive disorders in future generations, animal study finds
Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an animal study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Exposure to dioxins can worsen thyroid function
Exposure to dioxins can negatively impact thyroid function, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
BMI alone may not be a sufficient indicator of metabolic health
Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity, according to research being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Low food security linked to metabolic syndrome in reproductive-aged Latinx females
Not having reliable access to food has a significant relationship with metabolic syndrome, a condition that increases risk for diseases such as diabetes and heart disease, in Latinx females of reproductive age, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Duration and poor quality of sleep associated with greater risk for diabetes
Fewer than six hours or more than 10 hours of sleep, and poor quality of sleep are associated with a greater risk for diabetes, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Early time-restricted feeding improves blood sugar levels
Early-time restricted feeding, a type of intermittent fasting, improved fluctuations in blood glucose levels and decreased time above range, according to research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Many people with type 1 diabetes continue to struggle to control blood sugar surrounding exercise
Many people with type 1 diabetes struggle to exercise safely while keeping their blood sugar levels within a healthy range, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Teens with type 1 diabetes who see a pediatrician longer may have a smoother transition to adult care
Keeping adolescents with type 1 diabetes in pediatric diabetes care until at least age 17 may increase the chance that they will have a successful transition to adult care, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Breastfeeding may help mothers avoid type 2 diabetes
Breastfeeding can improve the number of insulin-producing cells in the pancreas and increase insulin sensitivity in mothers, helping to protect them against type 2 diabetes in later years, suggests a mice study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
CGM alarms often not set to alert children with diabetes to harmful blood glucose fluctuations
Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, according to a study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. This variability makes the monitors less useful in tracking glucose levels.
Statin alternative lowers risk of cardiac events as well as cholesterol levels
A medication called bempedoic acid reduced the risk of cardiac events as well as statins and may offer an alternative to the popular cholesterol-reducing medications, according to industry-supported research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.
Full recovery may be possible among men who use steroids for muscle growth
There may be hope for full recovery among men who wish to stop using anabolic-androgenic steroids for muscle growth, according to data being presented on Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Ali wins Wayne Bardin International Travel Award
The Endocrine Society selected Dalal S. Ali, M.D., as the recipient of its 2023 C. Wayne Bardin, MD, International Travel Award for her outstanding ENDO abstract and research contributions related to bone disease, calcium and endocrine disorders in pregnancy.
High copayments for novel therapies may reduce patients’ medication adherence
UCLA-led study shows that patients with diabetes and heart failure who have high medication copayments for novel therapies have a significantly lower chance of consistently adhering to these medications.
Endocrine Society congratulates 2023 Early Investigator Award winners
The Endocrine Society has selected five recipients for its Early Investigator Awards.
ENDO 2023 press conferences to highlight emerging technology and diabetes research
Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.
Rural patients with diabetes experience worse health outcomes than urban patients
Mayo Clinic researchers conducted a study within their health care system to identify factors associated with quality of care among rural and urban patients with diabetes. The study evaluated patient attainment of a five-component diabetic care metric, known as the D5 metric.
Endocrine Society’s new Scientific Statement identifies research gaps in pediatric, LGBTQIA care
In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations.
Niraula wins 2023 Endocrine Images Art Competition
Anzela Niraula, Ph.D., of the University of Washington in Seattle, won the Endocrine Society’s 2023 Endocrine Images Art Competition for her image of the microglia mandala. This contest celebrates the beauty of endocrine science, and entries were judged based on aesthetic value and significance to endocrine research.
Endocrine Society alarmed by Texas court ruling banning mifepristone
The Endocrine Society is deeply concerned about a Texas ruling that reverses the U.S. Food and Drug Administration’s (FDA) approval of mifepristone, a drug used to treat Cushing’s syndrome and to end pregnancy safely and effectively.
Endocrine Society supports EPA rule regulating “forever chemicals” in drinking water
The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water.